{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:03:55Z","timestamp":1776953035398,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ajo.2012.06.007","type":"journal-article","created":{"date-parts":[[2012,9,8]],"date-time":"2012-09-08T11:45:13Z","timestamp":1347104713000},"page":"940-948.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Short-Term Topical Bevacizumab in the Treatment of Stable Corneal Neovascularization"],"prefix":"10.1016","volume":"154","author":[{"given":"Sheng-Fu","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad H.","family":"Dastjerdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Okanobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kraig S.","family":"Bower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise S.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Amparo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedram","family":"Hamrah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nambi","family":"Nallasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Dana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajo.2012.06.007_bib1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2012.06.007_bib2","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archopht.1989.01070020226030","article-title":"Epidemiology of ocular herpes simplex: natural history in Rochester, Minn, 1950 through 1982","volume":"107","author":"Liesegang","year":"1989","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2012.06.007_bib3","first-page":"844","article-title":"Global data on visual impairment in the year 2002","volume":"82","author":"Resnikoff","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.ajo.2012.06.007_bib4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00003226-198706040-00004","article-title":"Corneal neovascularization","volume":"6","author":"Epstein","year":"1987","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2012.06.007_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0065-2776(08)60755-5","article-title":"Immune privilege and immune regulation in the eye","volume":"48","author":"Niederkorn","year":"1990","journal-title":"Adv Immunol"},{"issue":"12","key":"10.1016\/j.ajo.2012.06.007_bib6","first-page":"2485","article-title":"Loss and restoration of immune privilege in eyes with corneal neovascularization","volume":"37","author":"Dana","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2012.06.007_bib7","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0161-6420(94)31138-9","article-title":"Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies","volume":"101","author":"Maguire","year":"1994","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2012.06.007_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1568010053622830","article-title":"Role of inflammatory mediators in angiogenesis","volume":"4","author":"Naldini","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"1","key":"10.1016\/j.ajo.2012.06.007_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","article-title":"Angiogenesis in cancer, vascular, rheumatoid and other disease","volume":"1","author":"Folkman","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.ajo.2012.06.007_bib10","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)","volume":"104","author":"Azar","year":"2006","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"1","key":"10.1016\/j.ajo.2012.06.007_bib11","first-page":"18","article-title":"Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization","volume":"39","author":"Amano","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2012.06.007_bib12","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2012.06.007_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","article-title":"Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2012.06.007_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00006982-200603000-00005","article-title":"Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study","volume":"26","author":"Iturralde","year":"2006","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.ajo.2012.06.007_bib15","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.ophtha.2006.05.064","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2012.06.007_bib16","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/01.iae.0000230425.31296.3b","article-title":"Regression of neovascular iris vessels by intravitreal injection of bevacizumab","volume":"26","author":"Mason","year":"2006","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2012.06.007_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/02713680903395273","article-title":"Efficacy of topical bevacizumab for inhibiting growth of impending recurrent pterygium","volume":"35","author":"Fallah","year":"2010","journal-title":"Curr Eye Res"},{"issue":"4","key":"10.1016\/j.ajo.2012.06.007_bib18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","article-title":"Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study","volume":"127","author":"Dastjerdi","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2012.06.007_bib19","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","article-title":"The effect of topical bevacizumab on corneal neovascularization","volume":"115","author":"Kim","year":"2008","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2012.06.007_bib20","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-009-1099-1","article-title":"Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization","volume":"247","author":"Koenig","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"16","key":"10.1016\/j.ajo.2012.06.007_bib21","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1073\/pnas.90.16.7533","article-title":"Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium","volume":"90","author":"Quinn","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5047","key":"10.1016\/j.ajo.2012.06.007_bib22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.1312256","article-title":"The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor","volume":"255","author":"de Vries","year":"1992","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ajo.2012.06.007_bib23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.ajo.2012.06.007_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bjo.87.1.101","article-title":"Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation","volume":"87","author":"Cursiefen","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2012.06.007_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00003226-199807000-00011","article-title":"Topical modulation of interleukin-1 activity in corneal neovascularization","volume":"17","author":"Dana","year":"1998","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.ajo.2012.06.007_bib26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1167\/iovs.11-8014","article-title":"Imaging and evaluation of corneal vascularization using fluorescein and indocyanine green angiography","volume":"53","author":"Anijeet","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ajo.2012.06.007_bib27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ophtha.2006.10.045","article-title":"Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration","volume":"114","author":"Boyer","year":"2007","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2012.06.007_bib28","first-page":"361","article-title":"Ranibizumab: phase III clinical trial results","volume":"19","author":"Rosenfeld","year":"2006","journal-title":"Ophthalmol Clin North Am"},{"issue":"2","key":"10.1016\/j.ajo.2012.06.007_bib29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.expneurol.2004.01.022","article-title":"New roles for VEGF in nervous tissue\u2014beyond blood vessels","volume":"187","author":"Rosenstein","year":"2004","journal-title":"Exp Neurol"},{"issue":"8","key":"10.1016\/j.ajo.2012.06.007_bib30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/ICO.0b013e3181ca33d2","article-title":"Effect of intravitreal ranibizumab on corneal endothelium in age-related macular degeneration","volume":"29","author":"P\u00e9rez-Rico","year":"2010","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ajo.2012.06.007_bib31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/jop.2009.0056","article-title":"Effect of intracameral bevacizumab injection on corneal endothelial cells: an in vivo evaluation","volume":"25","author":"Hosny","year":"2009","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939412004382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939412004382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:06:56Z","timestamp":1757596016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939412004382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0002939412004382"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2012.06.007","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-Term Topical Bevacizumab in the Treatment of Stable Corneal Neovascularization","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2012.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}